Back to search

Article

5hmC and TET2 Dysregulation in Bladder Cancer: Diagnostic and Prognostic Implications

2026-06-05

Abstract excerpt

<title>Abstract</title> <p> BLCA remains a major clinical challenge due to high recurrence rates and the lack of reliable prognostic biomarkers. Since epigenetic dysregulation is a hallmark of urothelial carcinogenesis, we investigated the diagnostic and prognostic potential of 5hmC and TET2, a key regulator of active DNA demethylation. Immunohistochemical analysis of 5hmC and TET2 was performed in 133 BLCA samp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f563e08-e365-5eb1-b07d-9d5e32fb8a25
DOI
10.21203/rs.3.rs-9741262/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
5hmC and TET2 Dysregulation in Bladder Cancer: Diagnostic and Prognostic ImplicationsDOI 10.21203/rs.3.rs-9741262/v1
Select a neighboring publication to make it the new centre.